Tempus AI, Inc., established in 2015, is a technology company focused on applying artificial intelligence and data science to oncology. It develops a platform that integrates clinical and molecular data to provide real-time, actionable insights for healthcare professionals.
The company's technical domains include artificial intelligence, data science, genomics, and clinical informatics. Key products are Tempus One, an AI-enabled assistant for physicians; Lens, a data platform for clinical and molecular information; and genomic sequencing assays. Its platform connects with over 65% of academic medical centers and more than half of US oncologists, maintaining what is described as the world's largest clinical and molecular data library.
The organizational culture at Tempus AI emphasizes collaboration across disciplines, involving experts, innovators, biologists, data scientists, and cancer survivors, with a focus on impact and outcomes over traditional hierarchies.
